Small molecule resensitizes Salmonella to itaconate and decreases bacterial proliferation in macrophages
Duncan, D.; Chang, J. H.; Artyomov, M. N.; Auclair, K.
Show abstract
Antimicrobial resistance is a global health crisis offering little reprieve. The situation urgently calls for new drug targets and therapies for infections. We have previously suggested a different approach to treat infections, termed bacterio-modulation, in which a compound modulates the bacterial response to the host immune defense. Herein we show that monocytes infected with Salmonella enterica spp. Typhimurium can be cured using non-antimicrobial compounds that resensitize the bacterium to itaconate, a macrophage-derived antimicrobial metabolite. We propose that this represents a novel strategy to treat infections.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Broad-Spectrum Activity and Mechanisms of Action of SQ109 on a Variety of Fungi 94%
- The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators 92%
- Mammalian deubiquitinating enzyme inhibitors display in vitro and in vivo activity against malaria parasites and potentiate artemisinin action 92%
Similar papers in this journal
- Discovery of benzophenanthridine derivatives with potent activity against multidrug resistant Mycobacterium tuberculosis 95%
- Novel Pentafluorosulfanyl-containing Triclocarban Analogs selectively kill Gram-positive bacteria. 94%
- Polyether ionophore antibiotics target drug-resistant clinical isolates, persister cells, and biofilms 93%
Similar papers in this journal
- Importin alpha inhibitors act against the differentiated stages of apicomplexan parasites Plasmodium falciparum and Toxoplasma gondii 91%
- Enhanced Activity of Apramycin and Apramycin-Based Combinations Against Mycobacteroides abscessus 91%
- Outer membrane protein A (OmpA) deficient Salmonella Typhimurium displays enhanced susceptibility towards β-lactam antibiotics: third-generation cephalosporins (ceftazidime) and carbapenems (meropenem) 91%
Similar papers in this journal
- Amikacin potentiator activity of zinc complexed to a pyrithione derivative with enhanced solubility 93%
- Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections 93%
- Methylene Blue has a potent antiviral activity against SARS-CoV-2 in the absence of UV-activation in vitro 92%
Similar papers in this journal
- Targeting deubiquitinating enzymes (DUBs) and ubiquitin pathway modulators to enhance host defense against bacterial infections 93%
- Mefloquine reduces the bacterial membrane fluidity of Acinetobacter baumannii and distorts the bacterial membrane when combined with polymyxin B 92%
- Enhanced fungal specificity and in vivo therapeutic efficacy of a C-22 modified FK520 analog against C. neoformans 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.